Search This Blog

Monday, June 1, 2026

Invivyd completes enrollment in upsized Phase 3 of VYD2311 for prevention of symptomatic COVID-19

 

Invivyd completes enrollment in upsized Phase 3 trial of VYD2311 for prevention of symptomatic COVID-19

  • Top-line data from the Phase 3 DECLARATION pivotal trial of VYD2311 are expected in late Q3 2026.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)